FIELD: medicine.
SUBSTANCE: patient's blood plasma is analysed to measure the concentration of tissue inhibitor of metalloproteinase-1, and if the measured value is less than 381.3 ng/ml, the unfavourable clinical course accompanied by heart rhythm disorders is predicted.
EFFECT: using the invention provides the low invasiveness of the method, the absence of contra-indications, extensive applicability in medical facilities alongside with high sensitivity and specificity of the method.
3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTION OF HEART RHYTHM DISORDER IN PATIENTS WITH PRE-EXCITATION SYNDROME | 2014 |
|
RU2553346C1 |
| METHOD OF DIAGNOSING LEFT-SIDED LOCALISATION OF ADDITIONAL ATRIOVENTRICULAR CONNECTIONS IN CHILDREN WITH WOLFF-PARKINSON-WHITE SYNDROME | 2011 |
|
RU2471410C1 |
| METHOD FOR TREATING PATIENTS FOR PAROXYSMAL RECIPROCAL TACHICARDIA ON THE BACKGROUND OF WPW SYNDROME | 1999 |
|
RU2195983C2 |
| METHOD OF PREDICTING DEVELOPMENT OF CRITICAL STENOSIS OF CORONARY ARTERIES IN PATIENTS WITH ISCHEMIC HEART DISEASE | 2014 |
|
RU2550947C1 |
| PHARMACEUTICAL COMPOSITION PREVENTING DEVELOPMENT OF PREEXCITATION SYNDROME | 2011 |
|
RU2453313C1 |
| METHOD FOR PHARMACOLOGICAL AUTONOMIC HEART BLOCK | 2014 |
|
RU2572339C1 |
| METHOD FOR PREDICTION OF RISK OF UNFAVOURABLE OUTCOME IN PATIENTS WITH ACUTE CORONARY SYNDROME AND CONCOMITANT TYPE 2 DIABETES MELLITUS | 2014 |
|
RU2573499C1 |
| METHOD FOR PREDICTION OF DEVELOPING LIFE-THREATENING VENTRICULAR ARRHYTHMIAS IN PATIENTS WITH NO STRUCTURAL CARDIAC CHANGES | 2011 |
|
RU2456019C1 |
| METHOD OF DIAGNOSING PAROXYSMAL TACHYCARDIA | 2009 |
|
RU2411902C1 |
| METHOD FOR PREDICTION OF PROGRESSION OF CARDIOVASCULAR COMPLICATIONS OF ACUTE CORONARY SYNDROME WITH ST-SEGMENT ELEVATION | 2014 |
|
RU2567031C1 |
